Forbes: Arterya's CEO Lucile Derly Developing Medical Device
Photo by Natanael Melchor on Unsplash
Arterya CEO and co-founder, Lucile Derly, was included in Forbes' 2023 30 Under 30 Europe list for Science & Healthcare because her company is developing a medical device to improve arterial location accuracy. Arterya, founded in 2020, has raised $1.6 million and plans to begin clinical trials in French hospitals later this year.
Key takeaways
- Lucile Derly, co-founder and CEO of Arterya, has been named to Forbes' 2023 30 Under 30 - Europe - Science & Healthcare list
- Derly's company is developing a medical device intended to improve the accuracy of arterial location during essential procedures, including blood gas testing and the placement of stents or catheters
- Since its inception in 2020, Arterya has secured $1
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Verified mention available
Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.